Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.26 - $0.64 $549,702 - $1.35 Million
-2,114,241 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$0.85 - $1.33 $24,335 - $38,077
28,630 Added 1.37%
2,114,241 $1.78 Million
Q3 2021

Nov 12, 2021

BUY
$1.03 - $1.41 $898,543 - $1.23 Million
872,372 Added 71.9%
2,085,611 $2.52 Million
Q2 2021

Aug 16, 2021

BUY
$1.04 - $1.5 $1.26 Million - $1.82 Million
1,213,239 New
1,213,239 $1.33 Million

Others Institutions Holding NMTR

About 9 METERS BIOPHARMA, INC.


  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.